Putative trypsin-6 Antibodies

AND PRSS3P2 ELISA kits, Putative trypsin-6 Proteins

Many biological assays use antibodies to detect Putative trypsin-6, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with Putative trypsin-6 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop Putative trypsin-6 antibodies...

We validate the specificity of these antibodies to Putative trypsin-6 by testing them on tissues known to express PRSS3P2 positively and negatively. Browse below to find the PRSS3P2 antibody that suites your experiment. We have 0 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: FMC1

PRSS3P2 Infographic by Boster Bio

All PRSS3P2 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

PRSS3P2 Overview

Facts about Putative trypsin-6.

PRSS3P2 3D structure. Source: alphafold

Putative trypsin-6 (PRSS3P2)

May regulate cell migration. .

Gene Information

Human
Gene Name:	PRSS3P2
Uniprot:	Q8NHM4
Entrez:	154754

Family

Belongs to:

peptidase S1 family

Alternative Names

Putative trypsin-6

Molecular Weight

Mass (kDA):
26.537 kDA

Genomic Context


Human

Location:	7q34
Sequence:	7; NT_187562.1 (773503..777146)

Tissue Specificity

Overexpressed in metastasing in non small cell lung tumors, leading to an enhanced cell migration.

Subcellular Localizations

Secreted.

PTMs

Disulfide bond

Zymogen

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/PRSS3P2

References

PMID: 8650574 by Rowen L., et al. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus.

PMID: 15313892 by Diederichs S., et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.